MedPath

TIGRAN TECHNOLOGIES AB

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Reconstruction of Peri-implant Osseous Defects: A Randomized Trial

Not Applicable
Completed
Conditions
Peri-implantitis
First Posted Date
2015-04-01
Last Posted Date
2015-04-01
Lead Sponsor
Tigran Technologies AB
Target Recruit Count
70
Registration Number
NCT02406001
Locations
🇸🇪

Tigran Technologies AB, Malmö, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.